NANOSPHERE INC Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 13 Calls Today's Calls

Call Details NANOSPHERE INC Earnings Conference Call (Q1 2008) Tue, May 13, 2008, 5:00 pm Eastern Listen to the archived event audio About NANOSPHERE INC (NasdaqGM:NSPH) Nanosphere, Inc., a development stage company, develops, manufactures, and markets a molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. Its proprietary nanoparticle technology provides the ability to run multiple tests at the same time on the same sample, and enables the development of various test assays to be performed on a single platform. The company is developing diagnostic tests for a range of medical conditions, including cancer, neurodegenerative, cardiovascular, and infectious diseases, as well as pharmaco-genomics or tests for personalized medicine. It is also developing tests for genomic assays, including hyper-coagulation, warfarin metabolism, cystic fibrosis, herpes simplex virus, human papillomavirus, and respiratory virus panel; and protein assays, such as prostate specific antigen, cardiac troponin, and biomarker validation. Nanosphere was founded in 1998 and is headquartered in Northbrook, Illinois. More Info: Quote | Profile | Reports | Research | Insider | Financials | Analyst Ratings